Propensity-score-matched evaluation of under-recognition of acute kidney injury and short-term outcomes

被引:0
作者
Buyun Wu
Li Li
Xiaoyan Cheng
Wenyan Yan
Yun Liu
Changying Xing
Huijuan Mao
机构
[1] The First Affiliated Hospital of Nanjing Medical University,Department of Nephrology
[2] University of Electronic Science and Technology of China,Intensive Care Unit, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine
[3] The First Affiliated Hospital of Nanjing Medical University,Department of Information
来源
Scientific Reports | / 8卷
关键词
Acute Kidney Injury; Poor Short-term Outcome; Recognition Time (TR); Covariate Adjustment; SOFA Score;
D O I
暂无
中图分类号
学科分类号
摘要
Acute kidney injury (AKI) is a common disease, but diagnosis is usually delayed or missed in hospitalized patients. The aim of this study was to investigate the impact of under-recognition of AKI (beyond 3 days after AKI onset) on short-time prognosis. Of 785 patients with under-recognition of AKI and 616 patients with timely-recognition of AKI were propensity matched in a 1:1 ratio. The two groups, with a total of 482 matched patients (241:241), were comparable in baseline covariates. Under-recognition of AKI was not associated with 30-day all-cause mortality in the logistic regression model with covariate adjustment (OR = 1.01, 95% CI = 0.62–1.64, p = 0.967). Sensitivity analyses and subgroup analyses also proved the association. There were also no significant differences in causes of 30-day mortality, in-hospital mortality, recovery of renal function at discharge, length of hospital stay, length of intensive care unit stay or hospitalization costs between the two groups, although timely-recognition group had more chance of renal consult and a little more interventions for AKI. In conclusion, under-recognition of AKI may not be associated with poor short-term outcomes of adult hospitalized patients via these propensity-score-matched analyses.
引用
收藏
相关论文
共 39 条
[21]  
Wu B(2015)Automated, electronic alerts for acute kidney injury: a single-blind, parallel-group, randomised controlled trial Lancet 385 undefined-undefined
[22]  
Liu Y(undefined)undefined undefined undefined undefined-undefined
[23]  
Mao H(undefined)undefined undefined undefined undefined-undefined
[24]  
Xing C(undefined)undefined undefined undefined undefined-undefined
[25]  
Sundararajan V(undefined)undefined undefined undefined undefined-undefined
[26]  
Waters M(undefined)undefined undefined undefined undefined-undefined
[27]  
Nightingale P(undefined)undefined undefined undefined undefined-undefined
[28]  
Edwards JD(undefined)undefined undefined undefined undefined-undefined
[29]  
Vincent JL(undefined)undefined undefined undefined undefined-undefined
[30]  
Gaiao S(undefined)undefined undefined undefined undefined-undefined